# US 2025/0084085 A1 · Process of making 2-[(3r)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile and solvate forms thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084085 A1
- Document ID: US20250084085A1
- Status: Published application
- Kind: A1
- Application number: 18/789,827
- Filed: 2024-07-31
- Published: 2025-03-13
- Earliest claimed: 2023-08-01
- Assignees: Principia Biopharma Inc.
- Applicants: Principia Biopharma Inc.
- Inventors: Myriam Comte; Paul Cruciani; Laurent Larquetoux; Olivier Latremoliere; Clement Lemaitre; Philippe Ochsenbein; Pierre Versproumy
- Web page: https://patentgrep.com/patent/US20250084085A1

## CPC

- C07D 487/04: Ortho-condensed systems
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- C07D 305/08: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
- C07D 405/04: directly linked by a ring-member-to-ring-member bond
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed herein are novel methods for preparing 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile, including various solvate forms and intermediates thereof. Also disclosed herein are novel solvate forms and intermediates of 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile.

## Claims

### Claim 1

A method of preparing a compound of Formula (I):
or a salt thereof, comprising:
reacting a compound of Formula (I-g):
or a salt thereof, with a compound of Formula (I-n):
or a salt thereof, with amide-coupling reagent, organic base, and acid in organic solvent to form the compound of Formula (I).

### Claim 2 (depends on 1)

The method of claim 1, wherein the amide-coupling reagent is propylphosphonic anhydride.

### Claim 3 (depends on 1)

The method of claim 1, wherein the organic base is N-methylmorpholine, triethylamine, or diisopropylamine.

### Claim 4 (depends on 1)

The method of claim 1, wherein the acid is hydrochloric acid, methanesulfonic acid, paratoluenesulfonic acid, or chlorotoluenesulfonic acid.

### Claim 5 (depends on 1)

The method of claim 1, wherein the organic solvent comprises dichloromethane, dichloroethane, acetonitrile, chloroform, 2-methyltetrahydrofuran, tetrahydrofuran, methyl tert-butyl ether, toluene, chlorobenzene, methanol, ethanol, or isopropanol.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The method of claim 1, wherein the compound of Formula (I-n), or a salt thereof, is prepared by reacting a compound of Formula (I-l):
or a salt thereof, with a compound of Formula (I-m):
or a salt thereof, with inorganic or organic base in organic solvent to form the compound of Formula (I-n).

### Claim 8 (depends on 7)

The method of claim 7, wherein the inorganic base is sodium hydroxide, lithium hydroxide, or potassium hydroxide.

### Claim 9 (depends on 7)

The method of claim 7, wherein the organic base is sodium methoxide.

### Claim 10 (depends on 7)

The method of claim 7, wherein the organic solvent is alcohol.

### Claim 11

(canceled)

### Claim 12 (depends on 1)

The method of claim 1, wherein the compound of Formula (I-g), or a salt thereof, is prepared by reacting a compound of Formula (I-f):
or a salt thereof, with base in alcohol and water to form the compound of Formula (I-g).

### Claim 13 (depends on 12)

The method of claim 12, wherein the base is sodium hydroxide.

### Claim 14 (depends on 12)

The method of claim 12, wherein the alcohol is methanol.

### Claim 15 (depends on 1)

The method of claim 1, wherein the compound of Formula (I), or a salt thereof, is at least 95% by weight a compound of Formula (I-(E)):
or a salt thereof.

### Claim 16

A method of preparing a compound of Formula (I-n):
or a salt thereof, by reacting a compound of Formula (I-l):
or a salt thereof, with a compound of Formula (I-m):
or a salt thereof, with inorganic or organic base in organic solvent to form the compound of Formula (I-n).

### Claim 17 (depends on 16)

The method of claim 16, wherein the inorganic base is sodium hydroxide, lithium hydroxide, or potassium hydroxide.

### Claim 18 (depends on 16)

The method of claim 16, wherein the organic base is sodium methoxide.

### Claim 19 (depends on 16)

The method of claim 16, wherein the organic solvent is alcohol.

### Claim 20

(canceled)

### Claim 21

A method of preparing a compound of Formula (I-g):
or a salt thereof, by reacting a compound of Formula (I-f):
or a salt thereof, with base in alcohol and water to form the compound of Formula (I-g).

### Claim 22 (depends on 21)

The method of claim 21, wherein the base is sodium hydroxide.

### Claim 23 (depends on 21)

The method of claim 21, wherein the alcohol is methanol.

### Claim 24

A compound of Formula (I-n):
or a salt thereof.

### Claim 25

An ester solvate of a compound of Formula (I-(E)):

### Claim 26 (depends on 25)

The solvate form of claim 25, wherein the ester solvate is a methylacetate solvate.

### Claim 27 (depends on 26)

The solvate form of claim 26, wherein the methylacetate solvate has XRPD pattern comprising one or more peaks chosen from peaks at about 4.676° 2θ, 10.798° 2θ, 14.027° 2θ, 14.280° 2θ, 16.198° 2θ, and 16.704° 2θ.

### Claim 28

A carbonate solvate of a compound of Formula (I-(E)):

### Claim 29 (depends on 28)

The solvate form of claim 28, wherein the carbonate solvate is a dimethylcarbonate solvate.

### Claim 30 (depends on 29)

The solvate form of claim 29, wherein the dimethylcarbonate solvate characterized by an XRPD pattern comprising one or more peaks chosen from peaks at about 4.765° 2θ, 9.519° 2θ, 10.668° 2θ, 10.829° 2θ, 14.264° 2θ, and 16.976° 2θ.

### Claim 31 (depends on 26)

A method of preparing the methylacetate solvate of claim 26, wherein crystalline Form B of the compound of Formula (I-(E)) is dissolved in methylacetate to form a solution.

### Claim 32 (depends on 31)

The method of claim 31, wherein the solution is heated at a temperature ranging from 30 to 50° C. followed by cooling to a temperature ranging from 0 to 15° C.

### Claim 33 (depends on 26)

A method of preparing the methylacetate solvate of claim 26, wherein the amorphous compound of Formula (I-(E)) is dissolved in methylacetate to form a solution.

### Claim 34 (depends on 33)

The method of claim 33, wherein the solution is seeded with crystalline Form B of the compound of Formula (I-(E)) to form a suspension followed by stirring at a temperature ranging from 20 to 30° C.

### Claim 35 (depends on 29)

A method of preparing the dimethylcarbonate solvate of claim 29, wherein crystalline Form C of the compound of Formula (I-(E)) is dissolved in dimethylcarbonate to form a solution.

### Claim 36 (depends on 35)

The method of claim 35, wherein the solution is frozen, thawed, and stirred at a temperature ranging from 20 to 30° C. to induce particles that stay suspended in solution and do not sediment.

### Claim 37 (depends on 29)

A method of preparing the dimethylcarbonate solvate of claim 29, wherein the amorphous compound of Formula (I-(E)) is dissolved in dimethylcarbonate to form a solution.

### Claim 38 (depends on 37)

The method of claim 37, wherein the solution is seeded with crystalline Form B of the compound of Formula (I-(E)) to form a suspension.

### Claim 39 (depends on 38)

The method of claim 38, wherein the suspension is frozen at a temperature ranging from −10 to −30° C.

### Claim 40 (depends on 39)

The method of claim 39, wherein the frozen solution is thawed and stirred at a temperature ranging from 20 to 30° C.

### Claim 41 (depends on 26)

A method of preparing a mixture of crystalline Form A and crystalline Form B of a compound of Formula (I-(E)) from the methylacetate solvate of claim 26, wherein the methylacetate solvate is crystallized in 2-10% dichloromethane in methylacetate with seeds of crystalline Form B, a mixture of crystalline Form A and crystalline Form B, or wet methylacetate solvate of the compound of Formula (I-(E)) to form a suspension.

### Claim 42 (depends on 41)

The method of claim 41, wherein the methylacetate solvate is crystallized in 5-8% dichloromethane in methylacetate.

### Claim 43 (depends on 41)

The method of claim 41, wherein the suspension is cooled, filtered, and dried to yield a mixture of crystalline Form A and crystalline Form B of the compound of Formula (I-(E)).

### Claim 44 (depends on 43)

The method of claim 43, wherein the drying process is carried out at a pressure ranging from 0 to 800 mbars and a temperature ranging from 0 to 70° C.

### Claim 45 (depends on 41)

A method of preparing crystalline Form B of the compound of Formula (I-(E)), wherein the suspension of claim 41 is partially dissolved in ethanol and subjected to heating and cooling cycles at a temperature ranging from 0 to 50° C.

### Claim 46

(canceled)

### Claim 47 (depends on 45)

The method of claim 45, wherein the crystalline mixture is further cooled to a temperature of 0° C.

### Claim 48 (depends on 41)

A method of preparing crystalline Form B of the compound of Formula (I-(E)), wherein the suspension of claim 41 is partially dissolved in isopropylacetate and subjected to heating, cooling, and stirring.

### Claim 49 (depends on 48)

The method of claim 48, wherein the heating is carried out in 3-5 steps at a temperature ranging from 20 to 70° C. for 1 to 3 hours.

### Claim 50

(canceled)

### Claim 51 (depends on 48)

The method of claim 48, wherein the cooling is carried out at a temperature ranging from 15 to 40° C. within 1 to 3 hours followed by stirring for 8-16 hours.

### Claim 52

(canceled)

### Claim 53 (depends on 41)

A method of preparing crystalline Form B of the compound of Formula (I-(E)), wherein the suspension of claim 41 is subjected to pressure.

### Claim 54 (depends on 53)

The method of claim 53, wherein the pressure ranges from 30 to 70 bars.

### Claim 55 (depends on 53)

The method of claim 53, wherein the pressure is applied with inert gas.
